Development and characterization of a cell line for large‐scale, serum‐free production of recombinant adeno‐associated viral vectors

Abstract

AAV producer cell lines can be readily scaled to meet the needs of clinical trials. One 500 L bioreactor of these producer cells can produce the equivalent of 2500 high capacity roller bottles or 25 000 T-175 tissue culture flasks.